AI-generated summary
The authors studied photobiomodulation (660 nm red light) applied to the paws of mice with carrageenan-induced inflammation. They report that the treatment reduced paw swelling, and that this effect was reversed by blocking CB1 or CB2 cannabinoid receptors, with involvement of ATP-sensitive potassium channels and p38-MAPK signalling. The study was conducted in mice, so the findings may not apply directly to humans.
- Who or what was studied
- Mice
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract does not report a human sample.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 50 J/cm2
- Power
- 30 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Adenosine triphosphate, Inflammation, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.